PERBEDAAN GAMBARAN PEMERIKSAAN DARAH LENGKAP PRE DAN PASCA TERAPI TUBERKULOSIS FASE INTENSIF PADA PEDIATRI

Authors

  • Agustin Iskandar Fakultas Kedokteran Universitas Brawijaya
  • Ery Olivianto Fakultas Kedokteran Universitas Brawijaya
  • Rininta Dewi Syahfitri Fakultas Kedokteran Universitas Brawijaya
  • Luluk Maisaroh Fakultas Kedokteran Universitas Brawijaya
  • Ferine Ludytajati Fakultas Kedokteran Universitas Brawijaya
  • Andrea Aprilia Fakultas Kedokteran Universitas Brawijaya

Keywords:

leukosit, platelet, profil hematologi, TB anak, terapi intensif, tuberkulosis

Abstract

Tuberculosis (TBC) merupakan penyakit kronis yang banyak ditemui di Indonesia. Terapi yang diperlukan untuk mengeradikasi bakteri penyebab TBC (Mycobacterium tuberculosis) membutuhkan waktu setidaknya 6 bulan, yaitu 2 bulan fase intensif diikuti 4 bulan fase lanjutan. Selama ini, monitoring hasil terapi dilakukan setelah fase intensif dengan melakukan pemeriksaan mikrobiologis. Namun, pemeriksaan mikrobiologis kurang sensitif dan lebih sulit dilakukan khususnya pada anak sehingga diperlukan pemeriksaan lain yang lebih sederhana. Penelitian ini bertujuan untuk mengetahui profil hematologi yaitu profil eritrosit, leukosit, dan trombosit pre dan pasca terapi fase intensif obat antituberkulosis pada anak. Penelitian observasional analitik berdesain kohort prospektif dilakukan terhadap 90 pasien anak. dengan TBC paru maupun ekstra paru di Poli Kesehatan Anak RSUD dr. Saiful Anwar (RSSA) Malang pada Februari hingga Desember 2018. Hasil penelitian menggambarkan bahwa pada pasca terapi, jumlah leukosit (p = 0,036), neutrofil (p = 0,020), trombosit (p = 0,008), dan PCT (p = 0,015) lebih rendah namun jumlah limfosit (p = 0,037) lebih tinggi; sedangkan monosit, hemoglobin, indeks eritrosit, RDW, dan MPV tidak berbeda bermakna. Sekalipun demikian, jumlah leukosit, neutrofil, trombosit, plateletcrit (PCT) yang menurun serta jumlah limfosit yang lebih tinggi tidak berkorelasi dengan respons terapi pada TBC anak. Kesimpulan penelitian ini adalah terdapat penurunan leukosit, neutrofil, trombosit, PCT, dan peningkatan limfosit akan tetapi tidak berhubungan dengan respons pengobatan.

Author Biographies

Agustin Iskandar, Fakultas Kedokteran Universitas Brawijaya

Departemen Patologi Klinik

Ery Olivianto, Fakultas Kedokteran Universitas Brawijaya

Departemen Ilmu Kesehatan Anak

Rininta Dewi Syahfitri, Fakultas Kedokteran Universitas Brawijaya

Program Studi Sarjana Kedokteran

Luluk Maisaroh, Fakultas Kedokteran Universitas Brawijaya

Program Studi Sarjana Kedokteran

Ferine Ludytajati, Fakultas Kedokteran Universitas Brawijaya

Program Studi Sarjana Kedokteran

Andrea Aprilia, Fakultas Kedokteran Universitas Brawijaya

Departemen Patologi Klinik

References

Triasih R, Setyati A, Setyowireni D, Nuryastuti T, Putri R, Rusdiyati E. Use of Xpert MTB/RIF for Diagnosis of Pediatric Tuberculosis in Indonesia. Paediatrica Indonesiana. 2020;60(4): 198-204. https://doi.org/10.14238/pi60.4.2020.198-2042.

Ştefanescu S, Cocoş R, Turcu-Stiolica A, et al. Evaluation of Prognostic Significance of Hematological Profiles After the Intensive Phase Treatment in Pulmonary Tuberculosis Patients from Romania. PLoS One. 2021; 16(4):e0249301. Published 2021 Apr 1. doi:10.1371/journal.pone.0249301

Kurbatova EV, Cegielski JP, Lienhardt C, et al. Sputum Culture Conversion as A Prognostic Marker For End-of-Treatment Outcome In Patients With Multidrug-Resistant Tuberculosis: a Secondary Analysis of Data From Two Observational Cohort Studies. Lancet Respir Med. 2015;3(3):201-209. doi:10.1016/S2213-2600(15)00036-3

WHO. Treatment of Tuberculosis: Guidelines. 4th ed. Geneva: World Health Organization; 2010.

Horne, David J et al. Sputum Monitoring During Tuberculosis Treatment for Predicting Outcome: Systematic Review and Meta-Analysis. The Lancet. Infectious Diseases. 2010: 10(6):387-94. doi:10.1016/S1473-3099(10)70071-2.

Cohen, Sara B et al. Alveolar Macrophages Provide an Early Mycobacterium tuberculosis Niche and Initiate Dissemination. Cell Host & Microbe. 2018: (24)3:439-446.e4. doi:10.1016/j.chom.2018.08.001

Muefong CN, Sutherland JS. Neutrophils in Tuberculosis-Associated Inflammation and Lung Pathology. Front Immunol. 2020; 11:962. Published 2020 May 27. doi:10.3389/fimmu.2020.00962

de Mendonça EB, Schmaltz CA, Sant'Anna FM, et al. Anemia in Tuberculosis Cases: A Biomarker of Severity? [published correction appears in PLoS One. 2021 Mar 29;16(3):e0249545]. PLoS One. 2021;16(2):e0245458. Published 2021 Feb 2. doi:10.1371/journal.pone.0245458.

Kirwan DE, Chong DLW, Friedland JS. Platelet Activation and the Immune Response to Tuberculosis. Front Immunol. 2021;12:631696. Published 2021 May 19. doi:10.3389/fimmu.2021.631696

Borkute RR, Woelke S, Pei G, Dorhoi A. Neutrophils in Tuberculosis: Cell Biology, Cellular Networking and Multitasking in Host Defense. Int J Mol Sci. 2021; 22(9):4801. Published 2021 Apr 30. doi:10.3390/ijms22094801

Leem AY, Song JH, Lee EH, et al. Changes in Cytokine Responses to TB Antigens ESAT-6, CFP-10 and TB 7.7 and Inflammatory Markers in Peripheral Blood During Therapy. Sci Rep. 2018; 8(1):1159. Published 2018 Jan 18. doi:10.1038/s41598-018-19523-7

Mbatchou Ngahane B, Ebenezer A, Eveline N, Raïssa M, Fernando K, Lum C. and Henry N. Diagnostic Value of Leukocyte Count Abnormalities in Newly Diagnosed Tuberculosis Patients. Open Journal of Respiratory Diseases. 2020: 10:1-10. doi: 10.4236/ojrd.2020.101001.

Wang W, Wang LF, Liu YY, Yang F, Zhu L, Zhang XH. Value of the Ratio of Monocytes to Lymphocytes for Monitoring Tuberculosis Therapy. Can J Infect Dis Med Microbiol. 2019;2019:3270393. Published 2019 May 27. doi:10.1155/2019/3270393

La Manna MP, Orlando V, Dieli F, et al. Quantitative and Qualitative Profiles of Circulating Monocytes May Help Identifying Tuberculosis Infection and Disease Stages. PLoS One. 2017; 12(2):e0171358. Published 2017 Feb 16. doi:10.1371/journal.pone.0171358

Choudhary RK, Wall KM, Njuguna I, et al. Monocyte-to-Lymphocyte Ratio Is Associated With Tuberculosis Disease and Declines With Anti-TB Treatment in HIV-Infected Children. J Acquir Immune Defic Syndr. 2019; 80(2):174-181. doi:10.1097/QAI.0000000000001893

Mayito J, Meya DB, Rhein J, Sekaggya-Wiltshire C. Utility of the Monocyte to Lymphocyte Ratio in Diagnosing Latent Tuberculosis Among HIV-Infected Individuals With a Negative Tuberculosis Symptom Screen. PLoS One. 2020;15(11):e0241786. Published 2020 Nov 9. doi:10.1371/journal.pone.0241786

Kassa E, Enawgaw B, Gelaw A, Gelaw B. Effect of Anti-Tuberculosis Drugs on Hematological Profiles of Tuberculosis Patients Attending at University of Gondar Hospital, Northwest Ethiopia. BMC Hematol. 2016; 16:1. Published 2016 Jan 8. doi:10.1186/s12878-015-0037-1

Gil-Santana L, Cruz LAB, Arriaga MB, et al. Tuberculosis-Associated Anemia is Linked to a Distinct Inflammatory Profile that Persists After Initiation of Antitubercular Therapy. Sci Rep. 2019; 9(1):1381. Published 2019 Feb 4. doi:10.1038/s41598-018-37860-5

Torres-Juarez F, Trejo-Martínez LA, Layseca-Espinosa E, et al. Platelets Immune Response Against Mycobacterium Tuberculosis Infection. Microb Pathog. 2021; 153:104768. doi:10.1016/j.micpath.2021.104768

Yakar F, Yildiz N, Yakar A, Kılıçaslan Z. Isoniazid- and Rifampicin-Induced Thrombocytopenia. Multidiscip Respir Med. 2013; 8(1):13. Published 2013 Feb 13. doi:10.1186/2049-6958-8-13

Sari AP, Koesoemaprodjo W. Thrombocytopenia in Young Patient due to Anti Tuberculosis Drugs: A Case Report. Jurnal Respirasi. 2020;6(1):5-12.

Downloads

Published

31-03-2024

How to Cite

Iskandar, A., Olivianto, E., Syahfitri, R., Maisaroh, L., Ludytajati, F., & Aprilia, A. (2024). PERBEDAAN GAMBARAN PEMERIKSAAN DARAH LENGKAP PRE DAN PASCA TERAPI TUBERKULOSIS FASE INTENSIF PADA PEDIATRI. Majalah Kesehatan, 11(1), 24–30. Retrieved from https://majalahfk.ub.ac.id/index.php/mkfkub/article/view/537

Issue

Section

Original Research Article